Contact Us
Drug Search Results
More Filters [+]

Almotriptan

Alternative Names: almotriptan, axert
Latest Update: 2024-12-17
Latest Update Note: News Article

Product Description

Almotriptan is used to treat acute migraine headaches in adults and teenagers. It is not used to prevent migraine headaches and is not used for cluster headaches. Almotriptan works in the brain to relieve the pain from migraine headaches. It belongs to the group of medicines called triptans. (Sourced from: https://www.mayoclinic.org/drugs-supplements/almotriptan-oral-route/side-effects/drg-20061618?p=1)

Mechanisms of Action: 5-HT1 Agonist

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Approved

Approved Countries: Bangladesh | Belgium | Canada | Czech | Denmark | Egypt | Finland | France | Germany | Greece | Iceland | India | Ireland | Italy | Korea | Latvia | Lebanon | Lithuania | Luxembourg | Mexico | Netherlands | Norway | Peru | Poland | Portugal | Spain | Sweden | Switzerland | United Kingdom | United States

Approved Indications: Cluster Headache | Migraine Disorders | Migraine with Aura | Migraine without Aura | Acute Pain | Headache | Pain Unspecified

Known Adverse Events: Dizziness | Headache | Paresthesia

Company: None
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Almotriptan

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

Recent News Events

Date

Type

Title

12/17/2024

News Article

 Tonix Pharmaceuticals Announces FDA Acceptance of the New Drug Application (NDA) for TNX-102 SL for Fibromyalgia

12/03/2024

News Article

 Tonix Pharmaceuticals Announces Expansion of Leadership Team with Two Strategic Hires

11/14/2024

News Article

 Tonix Pharmaceuticals Targets Rapid Migraine Relief With Non-Oral Treatments

06/18/2024

News Article

 Tonix Pharmaceuticals Presented Data Comparing Real-World Treatment of Migraine with Industry Guidelines for Non-Oral Products at the Annual Scientific Meeting of the American Headache Society (AHS)

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions